Jong‐Il Choi
고려대학교 의과대학 · 의학
Jong-Il Choi 교수의 연구실은 심장 arrhythmia, 특히 심방세동 및 급성 빈맥 치료를 중심으로 한 전기생리학적 치료와 장기적인 임상 결과 관리에 중점을 두고 있습니다. 특히 심장 리모트 모니터링 시스템의 운영 체계, 약물 치료의 유전형별 효과 분석, 심방세동 ablation 후 재발 예측 요법 등 임상적 실용성을 고려한 연구를 진행하고 있습니다. 또한 심장 구조와 기능의 변화를 정량적으로 평가하는 영상 유도 생리학적 분석도 핵심 연구 분야입니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Remote monitoring is beneficial for the management of patients with cardiovascular implantable electronic devices by impacting morbidity and mortality. With increasing numbers of patients using remote monitoring, keeping up with higher volume of remote monitoring transmissions creates challenges for device clinic staff. This international multidisciplinary document is intended to guide cardiac electrophysiologists, allied professionals, and hospital administrators in managing remote monitoring c
This meta-analysis showed that beta-blockers were effective in reducing risk of cardiac events in patients with LQTS. Among them, nadolol was effective in LQT1 and LQT2, whereas other drugs showed different effectiveness depending on LQT genotype.
the late recurrence rate is higher in the patients with ERAT compared with those without ERAT following AF ablation, and is more often noted in the patients who underwent CTI ablation and had a prolonged procedure time. Furthermore, inducibility of AF or AT immediately after ablation independently predicts late recurrence in patients with ERAT.
The esterification of aqueous lactic acid solution with methanol and its reverse reaction catalyzed by acidic cation exchange resins in the H+ form were carried out in a batch system. The inhibiting effects of water and methanol on the resins were evaluated. The experimental data were correlated by a kinetic model that the inhibition by methanol and water was included. The reaction rate constants and the adsorption coefficients were determined from the experiments. The activity of acidic resin w
Reverse morphological remodeling of the LA occurred after successful ABL and ECV for AF. However, because LA function was lower in the ABL group than in the ECV group and did not recover to the baseline levels until 3 months after ABL, a meticulous anticoagulation program should be considered.